Patent · US Active

Polypeptides

US9211344B2 · kind B2 · utility

9Cited by

0References

45Claims

0Family size

Assignee

AFFIBODY AB · SE

Inventors

Caroline Ekblad · Boo, SE
Lars Abrahmsen · Bromma, SE

Key dates

Filing date	Jul 8, 2011
Grant date	Dec 15, 2015
Priority date	—
Expiry date	Jul 8, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to a class of engineered polypeptides having a binding affinity for albumin. It also relates to new methods and uses that exploit binding by these and other compounds to albumin in different contexts, some of which have significance for treatment or diagnosis of disease in mammals including humans.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.